Study of Usher Syndromes, Type 1 and Type 2
Sponsored by National Eye Institute (NEI)
About this trial
Last updated 17 years ago
Study ID
Status
Type
Placebo
Accepting
Not accepting
Trial Timing
Ended 23 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Patients must have documentation of neurosensory hearing loss and retinitis pigmentosa and fulfill the clinical characteristics (Table) as accepted for USH 1 and USH 2.
- The minimal test battery will identify all patients with USH 1 and USH 2 as well as possible subtypes.
- Candidates will be recruited from lists of patients willing to participate in research studies compiled by the R.P. Foundation, and by referral from their private physicians.
- On occasion additional family members will be studied after an initial individual is ascertained as above.
- No patients with intrauterine and childhood infections, and intrauterine and birth complications can result in trauma to both the auditory or visual system and a positive history for these conditions will necessitate exclusion from the study.